Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial

Author:

Colombo Nicoletta,Biagioli Elena,Harano Kenichi,Galli Francesca,Hudson Emma,Antill Yoland,Choi Chel Hun,Rabaglio Manuela,Marmé Frederic,Marth Christian,Parma Gabriella,Fariñas-Madrid Lorena,Nishio Shin,Allan Karen,Lee Yeh Chen,Piovano Elisa,Pardo Beatriz,Nakagawa Satoshi,McQueen John,Zamagni Claudio,Manso Luis,Takehara Kazuhiro,Tasca Giulia,Ferrero Annamaria,Tognon Germana,Lissoni Andrea Alberto,Petrella Mariacristina,Laudani Maria Elena,Rulli Eliana,Uggeri Sara,Barretina Ginesta M Pilar,Zola Paolo,Casanova Claudia,Arcangeli Valentina,Antonuzzo Lorenzo,Gadducci Angiolo,Cosio Stefania,Clamp Andrew,Persic Mojca,McNeish Ian,Tookman Laura,Redondo Sanchez Andrés,Choi Chel Hun,Baldini Editta,Palaia Innocenza,Benedetti Panici Pierluigi,Takahashi Nobutaka,Lombard Janine,Ardizzoia Antonio,Bologna Alessandra,Herrero Ibáñez Ana Maria,Musolino Antonino,Márquez Vázquez Raúl,Pietzner Klaus,Braicu Elena,Heinzelmann-Schwarz Viola A.,Powell Melanie,Yokoyama Yoshihito,Baron-Hay Sally,Abeni Chiara,Martin Lorente Cristina,Cueva Juan Fernando,Trillsch Fabian,Heitz Florian,Ataseven Beyhan,Petru Edgar,Heubner MartinLeonhard,Sadozye Azmat Hassanq,Dubey Sidharth,Tazbirkova Andrea,Tiley Susan,Chrystal Kathryn,Kim Sang Wun,Fehr Mathias,Scatchard Kate,Anand Anjana,Taylor Alexandra,Watary Hidemichi,Enomoto Takayuki,Yoshihara Kosuke,Selva-Nayagam Sudarsha,Karki Bhaskar,Harrison Michelle,Wilkinson Kate,Goh Jeffrey,Glasgow Amanda,Chantrill Lorraine,Lee Chulmin,Bertolini Alessandro,Narducci Filomena,Bellotti Giovanna,Fusco Vittorio,Aebi Stefan,Del Grande Maria,Colombo Ilaria,Tokunaga Hideki,Shigeta Shogo,Goss Geraldine,Siow Zhen Rong,Steer Christopher,Lin Hao,Lee Kwang-Beom,Di Meglio Giovanni,Massa Elena,De Marino Elvira,Tortora Vincenzo,Palacio Vazquez Isabel,Tsuji Kosuke,Tominaga Eiichiro,Goh Jeffrey,Black Allison,So Kyeong A,Suh Dong Hoon,Lee Keun Ho,Kim Yong Man,Fossati Roldano,Carlucci Luciano,Barberis Massimo,Torri Valter,Santoni Anna

Funder

F Hoffmann-La Roche Ltd

Publisher

Elsevier BV

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3